Anhui Fengyuan Pharmaceutical Co., Ltd. (SHE:000153)
China · Delayed Price · Currency is CNY 5.31
-0.03 (-0.56%)
Nov 13, 2026, 3:04 PM CST
SHE:000153 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 484.43 | 386.96 | 250.82 | 319.91 | 353.14 | 282.98 |
Short-Term Investments | - | - | - | - | 80.69 | - |
Cash & Short-Term Investments | 484.43 | 386.96 | 250.82 | 319.91 | 433.83 | 282.98 |
Cash Growth | 100.20% | 54.28% | -21.59% | -26.26% | 53.30% | 0.23% |
Accounts Receivable | 928.58 | 1,038 | 967.25 | 841.9 | 756.44 | 721.33 |
Other Receivables | 24.56 | 48.07 | 63.55 | 53.51 | 59.94 | 96.8 |
Receivables | 953.14 | 1,087 | 1,031 | 895.41 | 816.38 | 818.13 |
Inventory | 408.94 | 544.15 | 593.11 | 573.58 | 699.15 | 654.87 |
Prepaid Expenses | - | 1.83 | 1.16 | 2.92 | 3.61 | 6.18 |
Other Current Assets | 94.42 | 76.83 | 89.47 | 111.1 | 124.44 | 108.36 |
Total Current Assets | 1,941 | 2,096 | 1,965 | 1,903 | 2,077 | 1,871 |
Property, Plant & Equipment | 1,855 | 1,754 | 1,664 | 1,514 | 1,462 | 1,290 |
Long-Term Investments | 600.35 | 560.28 | 480.43 | 362.45 | 371.45 | 329.51 |
Goodwill | 4.66 | 4.66 | 7.92 | 7.92 | 7.92 | 7.92 |
Other Intangible Assets | 243.16 | 251.44 | 242.29 | 203.73 | 170.24 | 162.4 |
Long-Term Deferred Tax Assets | 50.8 | 64.83 | 58.99 | 60.24 | 39.98 | 37.67 |
Long-Term Deferred Charges | 106.47 | 100.21 | 98.84 | 117.64 | 106.32 | 94.66 |
Other Long-Term Assets | 169.96 | 227.39 | 181.22 | 222.58 | 234.26 | 266.08 |
Total Assets | 4,972 | 5,060 | 4,699 | 4,391 | 4,469 | 4,059 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 644.4 | 964.3 | 656.22 | 746.11 | 722.74 | 619.21 |
Accrued Expenses | 64.04 | 349.5 | 484.26 | 454.29 | 481.71 | 408.2 |
Short-Term Debt | 882.75 | 558.47 | 479.33 | 344.29 | 410.91 | 435.42 |
Current Portion of Long-Term Debt | 267.03 | 211.56 | 271.26 | 128.81 | 119.4 | 54.18 |
Current Portion of Leases | - | 17.4 | 20.64 | 19.71 | 17.47 | 21.48 |
Current Income Taxes Payable | 22.31 | 23.12 | 28.23 | 33.64 | 32.85 | 29.48 |
Current Unearned Revenue | 65.88 | 80.73 | 63.18 | 89.39 | 257.13 | 149.17 |
Other Current Liabilities | 356.91 | 171.36 | 184.98 | 197.41 | 302.43 | 223.1 |
Total Current Liabilities | 2,303 | 2,376 | 2,188 | 2,014 | 2,345 | 1,940 |
Long-Term Debt | 197.6 | 287.12 | 196.13 | 174.75 | 168.85 | 86 |
Long-Term Leases | 10.57 | 12.91 | 17.31 | 20.21 | 20.71 | 28.86 |
Long-Term Unearned Revenue | 232.47 | 229.69 | 227.2 | 238.05 | 151.92 | 150.88 |
Long-Term Deferred Tax Liabilities | 14.28 | 27.47 | 24.3 | 25.85 | 28.35 | 31.12 |
Other Long-Term Liabilities | - | - | - | - | - | 50.62 |
Total Liabilities | 2,758 | 2,934 | 2,653 | 2,472 | 2,714 | 2,288 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 464.69 | 464.77 | 464.77 | 332.03 | 332.11 | 312.14 |
Additional Paid-In Capital | 459.22 | 459.37 | 454.48 | 573.06 | 536.06 | 695.55 |
Retained Earnings | 1,134 | 1,101 | 1,042 | 931.21 | 805.14 | 681.93 |
Treasury Stock | - | -0.24 | - | - | - | - |
Comprehensive Income & Other | 134.57 | 78.96 | 58.07 | 53.11 | 55.18 | 52.17 |
Total Common Equity | 2,193 | 2,104 | 2,020 | 1,889 | 1,728 | 1,742 |
Minority Interest | 20.52 | 21.92 | 26.34 | 29.42 | 26.27 | 29.55 |
Shareholders' Equity | 2,213 | 2,126 | 2,046 | 1,919 | 1,755 | 1,771 |
Total Liabilities & Equity | 4,972 | 5,060 | 4,699 | 4,391 | 4,469 | 4,059 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,358 | 1,087 | 984.67 | 687.76 | 737.34 | 625.93 |
Net Cash (Debt) | -873.51 | -700.51 | -733.85 | -367.86 | -303.51 | -342.95 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.88 | -1.51 | -1.58 | -0.79 | -0.68 | -0.78 |
Filing Date Shares Outstanding | 464.61 | 464.69 | 464.77 | 464.84 | 464.96 | 437 |
Total Common Shares Outstanding | 464.61 | 464.77 | 464.77 | 464.84 | 464.96 | 437 |
Working Capital | -362.38 | -280.1 | -222.74 | -110.72 | -267.23 | -69.72 |
Book Value Per Share | 4.72 | 4.53 | 4.35 | 4.06 | 3.72 | 3.99 |
Tangible Book Value | 1,945 | 1,848 | 1,769 | 1,678 | 1,550 | 1,571 |
Tangible Book Value Per Share | 4.19 | 3.98 | 3.81 | 3.61 | 3.33 | 3.60 |
Buildings | - | 959.07 | 963.1 | 880.3 | 855.42 | 641.93 |
Machinery | - | 1,123 | 1,117 | 894.08 | 873.71 | 834.86 |
Construction In Progress | - | 626.92 | 445.12 | 524.13 | 439.38 | 458.25 |